LENSAR, Inc. $LNSR Shares Sold by Park West Asset Management LLC

Key Points

• Park West Asset Management LLC reduced its stake in LENSAR, Inc. by 89.3%, selling 723,613 shares and holding only 87,063 shares, representing about 0.74% of the company.
• LENSAR's stock had a negative earnings per share (EPS) of ($0.15) for the last quarter, missing estimates by ($0.07), with revenue reported at $11.36 million compared to expectations of $16.55 million.
• The company's stock trades at $12.17, with a market cap of $145.31 million and a one-year price range of $3.80 to $17.31.

Park West Asset Management LLC cut its holdings in LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 89.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 87,063 shares of the company's stock after selling 723,613 shares during the quarter. Park West Asset Management LLC owned 0.74% of LENSAR worth $1,229,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in LNSR. Groupe la Francaise acquired a new position in shares of LENSAR during the 1st quarter worth about $1,779,000. OMERS ADMINISTRATION Corp acquired a new stake in shares of LENSAR in the first quarter worth approximately $1,680,000. Huntleigh Advisors Inc. purchased a new stake in shares of LENSAR during the first quarter worth approximately $1,069,000. Draper Asset Management LLC acquired a new position in LENSAR in the 1st quarter valued at $565,000. Finally, Tabor Asset Management LP purchased a new position in LENSAR in the 1st quarter valued at $452,000. Hedge funds and other institutional investors own 40.15% of the company's stock.

LENSAR Stock Performance

Shares of NASDAQ:LNSR remained flat at $12.13 during midday trading on Thursday. 137,865 shares of the stock traded hands, compared to its average volume of 125,156. The stock has a market cap of $144.83 million, a P/E ratio of -2.88 and a beta of 0.49. LENSAR, Inc. has a 12-month low of $3.80 and a 12-month high of $17.31. The business's 50-day moving average is $12.77 and its 200 day moving average is $13.29.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.07). The company had revenue of $11.36 million during the quarter, compared to analysts' expectations of $16.55 million. LENSAR had a negative net margin of 84.49% and a negative return on equity of 737.30%.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.